Insider · CIK 0001195918
Mary K Brainerd
director
Files at SYK (STRYKER CORP). First filing Sep 2, 2026, latest Sep 2, 2026.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
1 / 0
$27k bought, $0 sold
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
SYK: STRYKER CORP
SYKOct 9, 2026 · close 277.33
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jun 26, 2019 | SYK STRYKER CORP | POpen-market purchase Common Stockindirect: Held by Husband's Revocable Trust | +63 | $202.21 | $13k | 63 | 40 d ago |
| Sep 12, 2019 | SYK STRYKER CORP | POpen-market purchase Common Stockindirect: Held by IRA | +11 | $221.03 | $2,431 | 0 | 40 d ago |
| May 12, 2020 | SYK STRYKER CORP | POpen-market purchase Common Stockindirect: Held by Husband's Revocable Trust | +36 | $193.21 | $6,956 | 99 | 40 d ago |
| Jun 12, 2020 | SYK STRYKER CORP | POpen-market purchase Common Stockindirect: Held by Husband's Revocable Trust | +3 | $185.65 | $557 | 102 | 40 d ago |
| Nov 22, 2022 | SYK STRYKER CORP | POpen-market purchase Common Stockindirect: Held by Husband's Revocable Trust | +18 | $225.20 | $4,054 | 131 | 40 d ago |
| May 8, 2025 | SYK STRYKER CORP | AGrant or award Common Stock | +560 | $0.00 | $0 | 7,028 | May 12, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.